June 2026 Research Update

This month included an early report suggesting that hands-on bodywork might help some gut symptoms in Pitt-Hopkins Syndrome, but the evidence is very limited. The report describes improvements after a short series of osteopathic manipulative treatment sessions, with no side effects noted, yet it cannot show whether the changes would happen in other children or without the treatment. [1]

In this single-child report, caregivers described the child as more relaxed and having fewer abdominal symptoms after five osteopathic manipulative treatment sessions, along with multiple daily bowel movements and less need for enemas. Pain scores recorded with a standard observational scale dropped early in the course and stayed below the starting level by the final visit. Because this was one patient and relied heavily on caregiver observations, it mainly adds a possible signal to study more carefully rather than a clear answer. [1]

For families dealing with constipation and belly discomfort in Pitt-Hopkins Syndrome, this report adds one concrete example of a non-drug, supportive approach that appeared well tolerated in the short term. It does not tell us how often this would help, how long benefits might last, or how it compares with usual constipation care, because there was only one child and no control group. For now, it mainly matters as early research that highlights constipation as a high-impact symptom and points to questions that larger, more objective studies could answer. [1]

This month added a clearer map of which brain cell types use TCF4 most strongly as the brain matures, based on primate tissue and supporting human datasets. The main pattern was a developmental shift: TCF4 starts out broadly present in neurons before birth, then becomes more concentrated in inhibitory nerve cells later on. This does not translate directly into symptoms, but it helps focus future research on specific cell populations that may be more sensitive to changes in TCF4. [2]

Across postnatal development in rhesus macaque neocortex, TCF4 labeling decreased in excitatory neurons and became enriched in inhibitory GABAergic interneurons. Among interneuron subtypes in young adulthood, SST- and CR-positive interneurons showed the highest TCF4 levels by tissue staining, PV was intermediate, and CCK-related cells were lower; public single-nucleus data supported the SST-over-PV-over-CCK ordering, though it ranked VIP (not CR) among the highest. The study also reported that TCF4 was mostly in neurons and showed little expression in glial cells, which helps narrow the kinds of brain cells researchers may prioritize when studying Pitt-Hopkins mechanisms. [2]

For patients and caregivers, this study is mainly about building a more precise picture of biology rather than changing care now. By indicating that TCF4 becomes especially active in certain inhibitory brain cells after birth, it helps clarify where researchers might look for downstream effects of TCF4 changes and which cell types might be most informative in future models and lab tests. What remains uncertain is how these cell-level patterns connect to specific Pitt-Hopkins features like communication, learning, sleep, breathing spells, or gut symptoms, because this work did not measure those outcomes. [2]